HomeBTAI • NASDAQ
add
BioXcel Therapeutics Inc
Previous close
$0.57
Day range
$0.49 - $0.55
Year range
$0.49 - $4.17
Market cap
20.76M USD
Avg Volume
402.71K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 214.00K | -37.24% |
Operating expense | 12.78M | -70.92% |
Net income | -13.65M | 72.96% |
Net profit margin | -6.38K | 56.92% |
Earnings per share | -0.32 | 79.78% |
EBITDA | -13.66M | 68.99% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 56.27M | -37.45% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | -74.30M | — |
Shares outstanding | — | — |
Price to book | -0.31 | — |
Return on assets | — | — |
Return on capital | -117.15% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -13.65M | 72.96% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2017
Headquarters
Website
Employees
74
